NO920855L - Medikamentinneholdende matrise - Google Patents
Medikamentinneholdende matriseInfo
- Publication number
- NO920855L NO920855L NO92920855A NO920855A NO920855L NO 920855 L NO920855 L NO 920855L NO 92920855 A NO92920855 A NO 92920855A NO 920855 A NO920855 A NO 920855A NO 920855 L NO920855 L NO 920855L
- Authority
- NO
- Norway
- Prior art keywords
- patient
- lollipop
- drug
- lipophilic
- medicine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Fremgangsmåter og sammensetninger for ikke-invasiv administrering av mediliamenteter på en dose til effekt måte for å gl en kardiovaskulær eller en nyrevaskulær aktivitet. Et kardlovaskulært eller nyrevaskulært medikament som er l stand til å bil absorbert gjennom \'r*~Z'> sllmhlnnevevene l munnen, svelget og spiserøret blir innarbeidet i en matrise som er i form av en sllkke- plnne. En pasient blir beroliget ved å få sllkkepinnen og medlkamentet går raskt Inn l pasientens blodstrøm etter som sllkkepinnen blir sugd på. ved behandling av pasienten, kan legen observere pasientens tilstand og fjerne sllkkepinnen når den har hatt den ønskede effekt for pasienten. En sllkkeplnne l hvilken et kardlo- vaskulært eller nyrevaskulært medikament har blitt spredd, er spesielt nyttig for å oppnå hurtig vaso- dllaterende, kalsium kanal blokkerende, beta-blokk- erende, seritonin resepter blokkerende, angina blokkerende, antl-hypertenslvé og hjertestimulerende effekter og for kontrollerlng av urlnmengde.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1989/003801 WO1991003233A1 (en) | 1989-09-05 | 1989-09-05 | Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO920855D0 NO920855D0 (no) | 1992-03-04 |
NO920855L true NO920855L (no) | 1992-04-10 |
Family
ID=22215208
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92920854A NO920854L (no) | 1989-09-05 | 1992-03-04 | Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter |
NO92920855A NO920855L (no) | 1989-09-05 | 1992-03-04 | Medikamentinneholdende matrise |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92920854A NO920854L (no) | 1989-09-05 | 1992-03-04 | Fremgangsmaate og sammensetninger for ikke-invasiv dose til effekt-administrering av lipofile medikamenter |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0493380B1 (no) |
JP (1) | JP2758985B2 (no) |
AT (1) | ATE159658T1 (no) |
AU (2) | AU645966B2 (no) |
DE (1) | DE68928415T2 (no) |
DK (1) | DK175773B1 (no) |
NO (2) | NO920854L (no) |
WO (1) | WO1991003233A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH624011A5 (no) * | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
EP0745380B1 (en) * | 1995-05-11 | 2005-08-03 | University Of Utah Research Foundation | Tobacco substitute |
US20060051413A1 (en) * | 2004-09-08 | 2006-03-09 | Chow Sing S M | Method of enhancing absorptions of transmucosal administration formulations |
US7776831B2 (en) * | 2006-02-01 | 2010-08-17 | Weg Stuart L | Use of antifungal compositions to treat upper gastrointestinal conditions |
US20160022643A1 (en) * | 2014-07-22 | 2016-01-28 | Professional Compounding Centers Of America | Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men |
US10525099B2 (en) | 2014-10-01 | 2020-01-07 | Oxytone Bioscience B.V. | Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance |
HUE051974T2 (hu) | 2014-10-01 | 2021-04-28 | Oxytone Bioscience B V | Szájban szétesõ, szülést szabályozó ágenst tartalmazó, szilárd halmazállapotú gyógyászati dózisegység |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
EP3955918A1 (en) | 2019-04-17 | 2022-02-23 | COMPASS Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2208120A (en) * | 1938-03-02 | 1940-07-16 | William B Coleman | Pharmaceutical preparation and method of making same |
US3943928A (en) * | 1974-09-25 | 1976-03-16 | Lariccia Anthony H | Eliminating the safety hazard in oral dissolution of a solid |
CA1208558A (en) * | 1982-10-07 | 1986-07-29 | Kazuo Kigasawa | Soft buccal |
US4551329A (en) * | 1984-01-20 | 1985-11-05 | Joan Harris | Oral medicament lollipop |
US4671953A (en) * | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
-
1989
- 1989-09-05 DE DE68928415T patent/DE68928415T2/de not_active Expired - Lifetime
- 1989-09-05 EP EP90902584A patent/EP0493380B1/en not_active Expired - Lifetime
- 1989-09-05 WO PCT/US1989/003801 patent/WO1991003233A1/en active IP Right Grant
- 1989-09-05 AT AT90902584T patent/ATE159658T1/de not_active IP Right Cessation
- 1989-09-05 AU AU50352/90A patent/AU645966B2/en not_active Ceased
- 1989-09-05 JP JP2502779A patent/JP2758985B2/ja not_active Expired - Lifetime
-
1992
- 1992-03-04 NO NO92920854A patent/NO920854L/no unknown
- 1992-03-04 NO NO92920855A patent/NO920855L/no unknown
- 1992-03-05 DK DK199200300A patent/DK175773B1/da not_active IP Right Cessation
-
1994
- 1994-04-27 AU AU60697/94A patent/AU6069794A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO920854L (no) | 1992-04-27 |
AU6069794A (en) | 1994-06-23 |
DK30092D0 (da) | 1992-03-05 |
EP0493380A1 (en) | 1992-07-08 |
WO1991003233A1 (en) | 1991-03-21 |
NO920855D0 (no) | 1992-03-04 |
DK175773B1 (da) | 2005-02-14 |
DE68928415D1 (de) | 1997-12-04 |
EP0493380B1 (en) | 1997-10-29 |
AU645966B2 (en) | 1994-02-03 |
JP2758985B2 (ja) | 1998-05-28 |
ATE159658T1 (de) | 1997-11-15 |
DE68928415T2 (de) | 1998-02-26 |
EP0493380A4 (en) | 1992-10-07 |
DK30092A (da) | 1992-05-05 |
NO920854D0 (no) | 1992-03-04 |
AU5035290A (en) | 1991-04-08 |
JPH05501854A (ja) | 1993-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
Kennedy et al. | Intravenous regional analgesia: an appraisal | |
DE69815122D1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
UY26425A1 (es) | Formulación y método antidiabético | |
ES2186693T3 (es) | Uso combinado del acido hialuronico y de agentes terapeuticos para mejorar el efecto terapeutico. | |
ATE111733T1 (de) | Verwendung von nikotin zur herstellung eines kit zur behandlung von krankheitszuständen, die auf eine nikotinbehandlung ansprechen. | |
DE69003392T2 (de) | Dosisform zur oralen verabreichung des hypoglykämischen glipizids. | |
JP2002532432A5 (no) | ||
NO920855L (no) | Medikamentinneholdende matrise | |
IL112288A (en) | Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases | |
BR9708388A (pt) | Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação. | |
ATE89737T1 (de) | Behandlung von leukozytstoerungen mit gm-csf. | |
DE69007065D1 (de) | Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten. | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
Duhault et al. | The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats | |
EP0397211A3 (en) | Percutaneous administration of 3'-azide-3'-deoxythymidine | |
CN2233753Y (zh) | 护心袋 | |
CN2224631Y (zh) | 药物保健袋 | |
RU94018748A (ru) | Лекарственный сбор для лечения больных с нарушениями сердечного ритма | |
王小马 | ELECTROIMPULSE ACUPUNCTURE TREATMENT OF 110 CASES OF ABDOMINAL PAIN AS A SEOUELA OF ABDOMINAL SURGERY | |
CN2219134Y (zh) | 中药治疗保健袋 | |
姚尊华 et al. | OBSERVATION ON 52 CASES OF PARALYSIS OF COMMON PERONEAL NERVE TREATED BY ACUPUNCTURE AND PLUM-BLOSSOM NEEDLING | |
RU93034329A (ru) | Лекарственный сбор для лечения желудочковой экстрасистолии | |
聂纯一 et al. | CLINICAL OBSERVATION ON THE EFFICACY OF 764-1 EYEDROPS IN TREATMENT OF CORNEAL SCARS | |
RU94000695A (ru) | Средство с противоаллергическим действием |